Literature DB >> 3331115

The role of the nucleus basalis of Meynert in dementia: review and reconsideration.

J L Cummings1, D F Benson.   

Abstract

The nucleus basalis of Meynert (nbM), a cholinergic nuclear group located in the sublenticular region, receives afferent input principally from the limbic system and projects to most of the cerebral cortex. The nucleus is atrophic in dementia of the Alzheimer type (DAT) and several other dementing disorders and attempts have been made to relate cholinergic deficits as well as intellectual impairment to nbM alterations. A cortical cholinergic deficit is routinely associated with atrophy of nbM, but there is no consistent relationship between changes in nbM and histopathologic alterations of the Alzheimer type and a variable association between nbM changes and dementia. The available information suggests that atrophy of nbM and cortical cholinergic deficits have a contributory role in several dementia syndromes but cannot account for many pathologic and behavioral aspects of these disorders.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3331115     DOI: 10.1097/00002093-198701030-00003

Source DB:  PubMed          Journal:  Alzheimer Dis Assoc Disord        ISSN: 0893-0341            Impact factor:   2.703


  7 in total

Review 1.  Orexin/hypocretin modulation of the basal forebrain cholinergic system: Role in attention.

Authors:  J Fadel; J A Burk
Journal:  Brain Res       Date:  2009-08-21       Impact factor: 3.252

Review 2.  Activating the damaged basal forebrain cholinergic system: tonic stimulation versus signal amplification.

Authors:  M Sarter; J P Bruno; P Dudchenko
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

3.  Acute and chronic effects of clozapine on cholinergic transmission in cultured mouse superior cervical ganglion neurons.

Authors:  Taixiang Saur; Bruce M Cohen; Qi Ma; Suzann M Babb; Edgar A Buttner; Wei-Dong Yao
Journal:  J Neurogenet       Date:  2016-09-14       Impact factor: 1.250

4.  Expression of the low-affinity nerve growth factor receptor enhances beta-amyloid peptide toxicity.

Authors:  S Rabizadeh; C M Bitler; L L Butcher; D E Bredesen
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-25       Impact factor: 11.205

5.  α7 Nicotinic Receptor Agonists: Potential Therapeutic Drugs for Treatment of Cognitive Impairments in Schizophrenia and Alzheimer's Disease.

Authors:  Jun Toyohara; Kenji Hashimoto
Journal:  Open Med Chem J       Date:  2010-05-27

Review 6.  Potential Pathways for Circadian Dysfunction and Sundowning-Related Behavioral Aggression in Alzheimer's Disease and Related Dementias.

Authors:  William D Todd
Journal:  Front Neurosci       Date:  2020-09-03       Impact factor: 5.152

7.  Risk factors for postoperative delirium in elderly patients after spinal fusion surgery.

Authors:  Sijin Choi; Inyoung Jung; Byunghoon Yoo; Sangseok Lee; Mun Cheol Kim
Journal:  Anesth Pain Med (Seoul)       Date:  2020-07-31
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.